OpenURL Connection Search

Select item for more details and to access through your institution.

Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).
Published in:
Journal of Pathology, 2007, v. 211, n. 5, p. 563, doi. 10.1002/path.2141
By:
- Ströbel, P;
- Murumägi, A;
- Klein, R;
- Luster, M;
- Lahti, M;
- Krohn, K;
- Schalke, B;
- Nix, W;
- Gold, R;
- Rieckmann, P;
- Toyka, K;
- Burek, C;
- Rosenwald, A;
- Müller-Hermelink, HK;
- Pujoll-Borrell, R;
- Meager, A;
- Willcox, N;
- Peterson, P;
- Marx, A
Publication type:
Article
The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis.
Published in:
Genes & Immunity, 2009, v. 10, n. 8, p. 667, doi. 10.1038/gene.2009.64
By:
- Chuang, W.-Y.;
- Ströbel, P.;
- Belharazem, D.;
- Rieckmann, P.;
- Toyka, K. V.;
- Nix, W.;
- Schalke, B.;
- Gold, R.;
- Kiefer, R.;
- Klinker, E.;
- Opitz, A.;
- Inoue, M.;
- Kuo, T.-t.;
- Müller-Hermelink, H. K.;
- Marx, A.
Publication type:
Article
Interaction between AChR-Specific T- and B-Line Lymphocytes: Antigen Presentation by B Hybridoma Cells and the Enhancing Effect of Monoclonal Antibodies on T-Cell Activationa.
Published in:
Annals of the New York Academy of Sciences, 1987, v. 505, n. 1, p. 71, doi. 10.1111/j.1749-6632.1987.tb51283.x
By:
- ZHANG, Y.;
- TZARTOS, S.;
- SCHALKE, B. C. G.;
- MELMS, A.;
- WEKERLE, H.
Publication type:
Article
The Thymus in Myasthenia Gravis: Functional and Morphological Studiesa.
Published in:
Annals of the New York Academy of Sciences, 1987, v. 505, n. 1, p. 797, doi. 10.1111/j.1749-6632.1987.tb51373.x
By:
- MELMS, A.;
- ENDLER, B.;
- KIRCHNER, TH.;
- SCHALKE, B. C. G.;
- MÜLLER-HERMELINK, H. K.;
- WEKERLE, H.
Publication type:
Article
Cyclosporin A Treatment of Myasthenia Gravis: Initial Results of a Double-Blind Trial of Cyclosporin A Versus Azathioprine.
Published in:
Annals of the New York Academy of Sciences, 1987, v. 505, n. 1, p. 872, doi. 10.1111/j.1749-6632.1987.tb51397.x
By:
- SCHALKE, B.;
- KAPPOS, L.;
- DOMMASCH, D.;
- ROHRBACH, E.;
- MERTENS, H. G.
Publication type:
Article
A CTLA4high genotype is associated with myasthenia gravis in thymoma patients.
Published in:
2005
By:
- Chuang W;
- Ströbel P;
- Gold R;
- Nix W;
- Schalke B;
- Kiefer R;
- Opitz A;
- Klinker E;
- Müller-Hermelink HK;
- Marx A
Publication type:
Journal Article
Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies.
Published in:
Journal of Surgical Oncology, 2013, v. 107, n. 7, p. 735, doi. 10.1002/jso.23321
By:
- Ried, M.;
- Potzger, T.;
- Braune, N.;
- Diez, C.;
- Neu, R.;
- Sziklavari, Z.;
- Schalke, B.;
- Hofmann, H.‐S.
Publication type:
Article
Neurofilament is an autoantigenic determinant in myasthenia gravis.
Published in:
1999
By:
- Schultz, Anja;
- Hoffacker, Viola;
- Wilisch, Annette;
- Nix, Wilfried;
- Gold, Ralf;
- Schalke, Berthold;
- Tzartos, Socrates;
- Müller-Hermelink, Hans-Konrad;
- Marx, Alexander;
- Schultz, A;
- Hoffacker, V;
- Wilisch, A;
- Nix, W;
- Gold, R;
- Schalke, B;
- Tzartos, S;
- Müller-Hermelink, H K;
- Marx, A
Publication type:
journal article

Found: 8

Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).

The PTPN22<sup>gain-of-function</sup>+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis.

Interaction between AChR-Specific T- and B-Line Lymphocytes: Antigen Presentation by B Hybridoma Cells and the Enhancing Effect of Monoclonal Antibodies on T-Cell Activation<sup>a</sup>.

The Thymus in Myasthenia Gravis: Functional and Morphological Studies<sup>a</sup>.

Cyclosporin A Treatment of Myasthenia Gravis: Initial Results of a Double-Blind Trial of Cyclosporin A Versus Azathioprine.

A CTLA4high genotype is associated with myasthenia gravis in thymoma patients.

Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies.

Neurofilament is an autoantigenic determinant in myasthenia gravis.